Lorvotuzumab

• Description:

  Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab) ) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  Approximately 146.44 kDa.

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  ADC Antibody

• CAS Number:

  339306-30-8